Are there side effects or safety concerns with GLP-1 booster medications
The reference ranges based on 1,160 alcohol abstainers are organized below (one retrospective meta-analysis and one clinical study) [11, 12]: The risk for heart disease increases around the middle of what is considered a normal range for both males and females (prospective clinical studies)
With our cast of characters in place, glucose, insulin, glucagon, GLP-1, GIP, and SGLT2, we can now move into the pharmacological management of diabetes with much more context for why each medication class works the way it does
Kurabi A, Keithley EM, Housley GD, Ryan AF, Wong AC
So thinking longer term, how durable are these improvements
The article explains that each component is chosen to keep the peptide stable and safe for subcutaneous injection rather than to add any therapeutic effect of its own